Stay updated on Tabelecleucel & Pembrolizumab in EBV+ NPC Clinical Trial
Sign up to get notified when there's something new on the Tabelecleucel & Pembrolizumab in EBV+ NPC Clinical Trial page.

Latest updates to the Tabelecleucel & Pembrolizumab in EBV+ NPC Clinical Trial page
- Check6 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0.SummaryDifference0.0%

- Check13 days agoChange DetectedThe page now shows Revision: v3.4.3, replacing Revision: v3.4.2.SummaryDifference0.0%

- Check20 days agoNo Change Detected
- Check28 days agoNo Change Detected
- Check42 days agoChange DetectedSite revision updated from v3.4.1 to v3.4.2 with no observable changes to study content or user-facing features. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check49 days agoChange DetectedRevision updated from v3.4.0 to v3.4.1; no user-facing content or functionality on the Study Details page appears to be affected. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check56 days agoChange DetectedUI updates include a Show glossary option and a new revision tag (v3.4.0). Minor label/capitalization changes were made to items like No FEAR Act Data and Last Update Submitted that Met QC Criteria, replacing older variants.SummaryDifference0.2%

- Check71 days agoChange DetectedSite revision updated from v3.3.3 to v3.3.4. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Tabelecleucel & Pembrolizumab in EBV+ NPC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Tabelecleucel & Pembrolizumab in EBV+ NPC Clinical Trial page.